Searched for
AMAN MEHTA TORRENT PHARMA
Government may soon launch scheme to develop critical minerals processing value chain: Recycling bodyThe initiative prioritizes recycling for 27 critical minerals, encouraging extraction and processing beyond just 'black mass'. The Material...
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
500 plants, 100 birds, 25 butterfly species: At 23, Delhi boy turns home terrace into lush urban forest. How a childhood love for birdwatching sparked a mission to protect urban wildlifeAman Sharma, a 23-year-old Delhi resident, has transformed his 15,000 sq ft terrace into a thriving urban forest, a testament to his passio...
Jefferies picks 9 power stocks with upside potential of up to 31%. How many do you own?Jefferies identifies the power sector as a compelling investment theme, anticipating significant growth. The firm has issued Buy ratings on...
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
New policy formulated for evaluation of Private CBSE students in Gulf countries: Centre to Supreme CourtThe Supreme Court was informed by the Centre about a new CBSE policy for private students whose Class XII exams in Gulf countries were canc...
He rejected 'dollar paycheck' in Singapore to live in Bengaluru: Techie walks away from dream job. Is it the right choice?An Indian tech professional, Aman Vaishnav, has gone viral after revealing why he left a high-paying machine learning job in Singapore and ...
Tarun Tejpal case: Bombay High Court to hear concluding arguments by State of Goa on June 24During the Bombay High Court hearing on Tarun Tejpal's acquittal in a rape case, the State argued the complainant was "virtually put on tri...
Two techies from India and Pakistan built an AI startup - Now both are billionaires thanks to Elon Musk. Here's all about Aman Sanger and Sualeh AsifTwo young entrepreneurs, Aman Sanger from India and Sualeh Asif from Pakistan, have joined the billionaire ranks. Their company, Cursor, a ...
NSE IPO to create significant value for investors; Tata Motors a strong long-term bet: Dipan MehtaDipan Mehta of Elixir Equities views the National Stock Exchange's IPO as a significant event for India's capital markets, promising greate...
Top actresses rejected him, labelled as a B-grade star. He was told he could never become a hero. How a St. Xavier's College educated model-actress helped rewrite the superstar's destinyMithun Chakraborty faced several rejections and doubts early in his Bollywood career, with many actresses unwilling to work with him. His s...
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
NBFCs and private banks better positioned than PSU banks: Aman ChowhanAman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...